Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism

doi:10.5527/wjn.v5.i5.437

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9618)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-9) series.

Item

Count

PDF

404

WORD

391

HTML

3374

Figures (1-1)

237

Tables (1-9)

261

Sum=4667

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

517

Download

1183

Sum=1700

Publishing Process of This Article

Item

Count

Browse

1190

Download

2061

Sum=3251

Sep 6, 2016 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Nephrol. Sep 6, 2016; 5(5): 437-447
Published online Sep 6, 2016. doi: 10.5527/wjn.v5.i5.437

Table 1 Initial dose of vitamin D analogue (calcitriol) to treat secondary hyperparathyroidism due to chronic kidney disease

PTH level	Vitamin D analogue dose (calcitriol)
PTH 200-499 pg/mL	0.25 mcg qd once a day
PTH 500-999 pg/mL	0.50 mcg qd or 1 mcg qd once a day/3 times a week
PTH > 1000 pg/mL	2.0 mcg qd once a day/3 times a week

Source: Minas Gerais Health Authority (Secretaria do Estado da Saúde de Minas Gerais). Available from: URL: http://www.saude.mg.gov.br/atos_normativos/resolucoes/2003. PTH: Parathyroid hormone.

Citation: Ribeiro C, Penido MGMG, Guimarães MMM, Tavares MS, Souza BDN, Leite AF, de Deus LMC, Machado LJC. Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism. World J Nephrol 2016; 5(5): 437-447
URL: https://www.wjgnet.com/2220-6124/full/v5/i5/437.htm
DOI: https://dx.doi.org/10.5527/wjn.v5.i5.437